Capgemini’s Post

Gen AI is pushing the pharmaceutical industry over its hurdles, and into a new frontier. Growing challenges have been hindering the drug development process and slowing the rate at which new drugs enter the market. These include high costs, increased risk, and lengthy discovery timelines. Gen AI is positioned to completely transform the drug development lifecycle, with potential to: • Accelerate drug discovery • Streamlining in clinical trials • Drive personalized patient care Recognizing this potential, pharma leaders everywhere are searching for ways to leverage the technology within their business. Read our latest blog with Bayer to explore the full potential of Gen AI for pharma https://bit.ly/3G5B8EU #Capgemini #GenAI #Pharma